{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:03Z","timestamp":1786980483765,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"navamindradhiraj\u202funiversity\u202fresearch fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10067-021-05872-8","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T01:11:32Z","timestamp":1629249092000},"page":"213-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Early versus Late Allopurinol Initiation in Acute Gout Flare (ELAG): a randomized controlled trial"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-3789","authenticated-orcid":false,"given":"Panchalee","family":"Satpanich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjak","family":"Pongsittisak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn","family":"Manavathongchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"issue":"1","key":"5872_CR1","first-page":"27","volume":"58","author":"T Pascart","year":"2019","unstructured":"Pascart T, Liot\u00e9 F (2019) Gout: state of the art after a decade of developments. Rheumatology (Oxford) 58(1):27\u201344","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"5872_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","volume":"76","author":"P Richette","year":"2017","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Casta\u00f1eda-Sanabria J et al (2017) 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29\u201342","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"5872_CR3","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/rheumatology\/kex150","volume":"56","author":"M Hui","year":"2017","unstructured":"Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H et al (2017) The British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford) 56(7):1056\u20131059","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5872_CR4","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM et al (2020) 2020 American College of Rheumatology guideline for the management of gout. Arthritis Care Res (Hoboken) 72(6):744\u2013760","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"5872_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/RHU.0000000000000235","volume":"21","author":"EM Hill","year":"2015","unstructured":"Hill EM, Sky K, Sit M, Collamer A, Higgs J (2015) Does starting allopurinol prolong acute treated gout? A randomized clinical trial. J Clin Rheumatol 21(3):120\u2013125","journal-title":"J Clin Rheumatol"},{"issue":"11","key":"5872_CR6","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.amjmed.2012.05.025","volume":"125","author":"TH Taylor","year":"2012","unstructured":"Taylor TH, Mecchella JN, Larson RJ, Kerin KD, Mackenzie TA (2012) Initiation of allopurinol at first medical contact for acute attacks of gout: a randomized clinical trial. Am J Med 125(11):1126\u201334.e7","journal-title":"Am J Med"},{"issue":"Suppl 3","key":"5872_CR7","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4174","volume":"15 Suppl 3","author":"LJ Crofford","year":"2013","unstructured":"Crofford LJ (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15 Suppl 3(Suppl 3):S2","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5872_CR8","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3899\/jrheum.131246","volume":"41","author":"JA Singh","year":"2014","unstructured":"Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R et al (2014) OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol 41(3):569\u2013573","journal-title":"J Rheumatol"},{"issue":"3","key":"5872_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/art.40381","volume":"70","author":"AL Gaffo","year":"2018","unstructured":"Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS et al (2018) Brief Report: Validation of a definition of flare in patients with established gout. Arthritis Rheumatol 70(3):462\u2013467","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5872_CR10","first-page":"51","volume":"1","author":"B Zhong","year":"2009","unstructured":"Zhong B (2009) How to calculate sample size in randomized controlled trial? J Thorac Dis 1(1):51\u201354","journal-title":"J Thorac Dis"},{"issue":"7","key":"5872_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.7326\/M14-2070","volume":"164","author":"TH Rainer","year":"2016","unstructured":"Rainer TH, Cheng CH, Janssens HJ, Man CY, Tam LS, Choi YF et al (2016) Oral prednisolone in the treatment of acute gout: a pragmatic, multicenter, double-blind, randomized trial. Ann Intern Med 164(7):464\u2013471","journal-title":"Ann Intern Med"},{"issue":"1","key":"5872_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1001\/jama.1978.03280280034020","volume":"239","author":"MC Schweitz","year":"1978","unstructured":"Schweitz MC, Nashel DJ, Alepa FP (1978) Ibuprofen in the treatment of acute gouty arthritis. JAMA 239(1):34\u201335","journal-title":"JAMA"},{"issue":"2","key":"5872_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000512178","volume":"30","author":"AFG Cicero","year":"2021","unstructured":"Cicero AFG, Fogacci F, Cincione RI, Tocci G, Borghi C (2021) Clinical effects of xanthine oxidase inhibitors in hyperuricemic patients. Med Princ Pract 30(2):122\u2013130","journal-title":"Med Princ Pract"},{"issue":"9","key":"5872_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","volume":"19","author":"W Tassaneeyakul","year":"2009","unstructured":"Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U et al (2009) Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 19(9):704\u2013709","journal-title":"Pharmacogenet Genomics"},{"issue":"8","key":"5872_CR15","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/art.34488","volume":"64","author":"LK Stamp","year":"2012","unstructured":"Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C et al (2012) Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum 64(8):2529\u20132536","journal-title":"Arthritis Rheum"},{"issue":"1","key":"5872_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/medicina57010058","volume":"57","author":"AFG Cicero","year":"2021","unstructured":"Cicero AFG, Fogacci F, Kuwabara M, Borghi C (2021) Therapeutic strategies for the treatment of chronic hyperuricemia: an evidence-based update. Medicina (Kaunas) 57(1):58","journal-title":"Medicina (Kaunas)"},{"issue":"4","key":"5872_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/14740338.2019.1594771","volume":"18","author":"L Strilchuk","year":"2019","unstructured":"Strilchuk L, Fogacci F, Cicero AF (2019) Safety and tolerability of available urate-lowering drugs: a critical review. Expert Opin Drug Saf 18(4):261\u2013271","journal-title":"Expert Opin Drug Saf"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05872-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05872-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05872-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T11:19:08Z","timestamp":1641295148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05872-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["5872"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05872-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"25 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethical review and approval were obtained from the Institutional Review Board of\u00a0Vajira\u00a0Hospital (COA137\/61).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}